INVO Fertility (IVF) Cash from Investing Activities (QoQ) (2019 - 2025)
INVO Fertility (IVF) Cash from Investing Activities (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | INVO Fertility | 1.54 Mn | -3.36 Mn | 732,978.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 47.81% |
| Jun 30, 2025 | -5.43% |
| Mar 31, 2025 | -103.73% |
| Jun 30, 2024 | 78.72% |
| Mar 31, 2024 | -172.42% |
| Dec 31, 2023 | 101.47% |
| Sep 30, 2023 | -763.55% |
| Jun 30, 2023 | -2,995.83% |
| Mar 31, 2023 | -198.42% |
| Dec 31, 2022 | 385.34% |
| Sep 30, 2022 | 38.64% |
| Jun 30, 2022 | 94.01% |
| Mar 31, 2022 | 91.08% |
| Dec 31, 2021 | -186.56% |
| Sep 30, 2021 | 47.18% |
| Jun 30, 2021 | -96.26% |
| Mar 31, 2021 | -219.95% |
| Dec 31, 2020 | -58.44% |
| Sep 30, 2020 | -1,226.49% |
| Jun 30, 2020 | 81.72% |